Koninklijke Philips | PHG - Sales Revenues


Koninklijke Philips reported EUR4.51B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Baxter International USD 2.7B 270M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Boston Scientific USD 5.2B 90M Mar/2026
Danaher USD 5.95B 890M Mar/2026
Demant DKK 6.25B 800M Dec/2025
Dexcom USD 1.19B 70M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
Fresenius EUR 5.74B 140M Mar/2026
General Electric Aerospace USD 11.6B 270M Mar/2026
Getinge SEK 11.07B 3.2B Dec/2024
Globus Medical USD 759.85M 66.55M Mar/2026
GN Store Nord DKK 3.85B 830M Mar/2026
Hitachi JPY 3.08T 370B Mar/2026
Idexx Laboratories USD 1.14B 50M Mar/2026
Insulet USD 761.7M 22.1M Mar/2026
Integra LifeSciences USD 391.9M 43M Mar/2026
Intuitive Surgical USD 2.77B 100M Mar/2026
J&J USD 24.1B 500M Mar/2026
Koninklijke Philips EUR 4.51B 1.42B Mar/2026
Masimo USD 403.6M 8.9M Mar/2026
Medtronic USD 9.8B 800M Mar/2026
Philips EUR 3.91B 1.19B Mar/2026
ResMed USD 1.4B 0 Mar/2026
Smith & Nephew USD 3.18B 353M Dec/2025
Steris USD 1.59B 90M Mar/2026
Stryker USD 6B 1.2B Mar/2026
Teleflex USD 548.3M 20.68M Mar/2026
Terumo JPY 300.32B 3.69B Mar/2026
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026